Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Pacific Region Node


The Pacific Region Node is a partnership between the Regents of the University of California, Los Angeles and several community treatment programs in the State. The node incorporates researchers and clinicians from throughout California. Many of the CTP networks have been involved in the transfer of research into practice for over a decade. The diverse communities served by the CTPs have geographic areas with epidemic methamphetamine use, increasing rates of heroin use among youthful populations, endemic inner city crack cocaine use, and dramatically increasing reports of the use of ecstasy and GHB.

 

Regional Research and Training Center

The Regents of the University of California, Los Angeles
Sponsored Research
Box 951406
1401 Ueberroth Building
Los Angeles, CA 90095-1406


Principal Investigator

Walter Ling, M.D.
Director
Integrated Substance Abuse Program, UCLA
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
310-312-0500 Ext 317 (Voice)
lwalter@ix.netcom.com

Community Treatment Programs

Bay Area Addiction Research/Treatment
La Puente, CA

Betty Ford Center
Rancho Mirage, CA

Haight-Ashbury Free Clinic
San Francisco, CA

Hina Mauka Kaneohe Rehabilitation Services
Kaneohe, HI

Integrated Substance Abuse Programs (ISAP-UCLA)
Los Angeles, CA

Les Kelley Family Health Center (ISAP-UCLA)
Santa Monica, CA

Matrix Institute on Addictions
Los Angeles, CA

Phoenix House of California
Lake View Terrace, CA

Tarzana Treatment Centers
Tarzana, CA


Pacific Region Protocol Involvement
PROTOCOL0001 Buprenorphine/Naloxone for Opiate Detoxification - INpatient
PROTOCOL0002 Buprenorphine/Naloxone for Opiate Detoxification - OUTpatient
PROTOCOL0004 Motivational Enhancement Treatment (MET)
PROTOCOL0006 Motivational Incentives - Drug Free Clinics
PROTOCOL0007 Motivational Incentives - Methadone Clinics
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0009 Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy In Substance Abuse Rehabilitation Programs
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
PROTOCOL0027 Starting Treatment with Agonist Replacement Therapies - START
PROTOCOL0030 Prescription Opioid Addiction Treatment Study (POATS)
PROTOCOL0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, December 1, 2008. The U.S. government's official web portal